Evaluation of laccases and melanization in clinical and environmental Cryptococcus neoformans samples by non-denaturing PAGE

Journal of Medical Microbiology

Volumn 58, Issue 5, 2009, Pages 563-566

  Pereira, Cristiane B ^a   Bueno, Frank L ^a   Dias, Amanda L T ^a   Brigagão, Maísa R P L ^a   Paula, Claudete R ^b   Siqueira, Antonio M ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LACCASE; LEVODOPA; MELANIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DENSITOMETRY; ENVIRONMENTAL STRESS; HOST RESISTANCE; INCUBATION TIME; MELANOGENESIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEROTYPE; VIRULENCE;

BRAZIL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMANS; IMMUNOCOMPROMISED HOST; LACCASE; MELANINS; SEROTYPING;

EID: 67650444838     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.007716-0     Document Type: Article

References (25)

1. Blackstock, R., Buchanan, K. L., Cherniak, R., Mitchell, T. G., Wong, B., Bartiss, A., Jackson, L. & Murphy, J. W. (1999). Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia 147, 1-11. (Pubitemid 30388007)
2. Bradford, M. M. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
3. Casadevall, A. & Perfect, J. R. (1998). Cryptococcus neoformans, 1st edn. Washington, DC: American Society for Microbiology.
4. Chen, J., Varma, A., Diaz, M. R., Litvintseva, A. P., Wollenberg, K. K. & Kwon-Chung, K. J. (2008). Cryptococcus neoformans strains and infections in apparently immunocompetent patients, China. Emerg Infect Dis 14, 755-762. (Pubitemid 351838639)
5. Fernandes, O. de F. L., Costa, T. R., Costa, M. R., Soares, A. J., Pereira, A. J. S. C. & Silva, M. R. R. (2000). Cryptococcus neoformans isolados de pacientes com AIDS. Rev Soc Bras Med Trop 33, 75-78.
6. Garcia-Rivera, J., Eisenman, H. C., Nosanchuk, J. D., Aisen, P., Zaragoza, O., Moadel, T., Dadachova, E. & Casadevall, A. (2005). Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates. Fungal Genet Biol 42, 989-998. (Pubitemid 41654534)
7. Hamilton, A. J. & Gomez, B. L. (2002). Melanin in fungal pathogens. J Med Microbiol 51, 189-191.
8. Ikeda, R. & Jacobson, E. S. (1992). Heterogeneity of phenol oxidases in Cryptococcus neoformans. Infect Immun 60, 3552-3555.
9. Ikeda, R., Sugita, T., Jacobson, E. S. & Shinoda, T. (2002). Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans. J Clin Microbiol 40, 1214-1218. (Pubitemid 34279878)
10. Khan, Z. U., Randhawa, H. S., Kowshik, T., Chowdhary, A. & Chandy, R. (2007). Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India. J Antimicrob Chemother 60, 312-316. (Pubitemid 47243879)
11. Kokturk, N., Ekim, N., Kervan, F., Arman, D., Memis, L., Çaglar, K., Kalkanci, A., Demircan, S., Kurul, C. & Akyurek, N. (2005). Disseminated cryptococcosis in a human immunodeficiency virus-negative patient: a case report. Mycoses 48, 270-274. (Pubitemid 40965947)
12. Kovacs, J. A., Kovacs, A. A., Polis, M., Wright, W. C., Gill, V. J., Tuazon, C. U., Gelmann, E. P., Lane, H. C., Longfield, R. & other authors (1985). Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 103, 533-538.
13. Kozel, T. R. (1995). Virulence factors of Cryptococcus neoformans. Trends Microbiol 3, 295-299.
14. Kwon-Chung, K. J. & Rhodes, J. C. (1986). Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 51, 218-223. (Pubitemid 16200022)
15. Kwon-Chung, K. J., Polacheck, I. & Popkin, T. J. (1982). Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 150, 1414-1421. (Pubitemid 12015849)
16. Mitchell, T. G. & Perfect, J. R. (1995). Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8, 515-548.
17. Nosanchuk, J. D. & Casadevall, A. (2003). The contribution of melanin to microbial pathogenesis. Cell Microbiol 5, 203-223.
18. Pinner, R. W., Hajjeh, R. A. & Powderly, W. G. (1995). Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis 21 (Suppl. 1), S103-S107.
19. Plonka, P. M. & Grabacka, M. (2006). Melanin synthesis in microorganisms - biotechnological and medical aspects. Acta Biochim Pol 53, 429-443. (Pubitemid 44563711)
20. Rozenbaum, R. & Gonçalves, A. J. R. (1994). Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 18, 369-380. (Pubitemid 24086307)
21. Shaw, C. E. & Kapica, L. (1972). Production of diagnostic pigment by phenoloxidase activity of Cryptococcus neoformans. Appl Microbiol 24, 824-830.
22. Steenbergen, J. N. & Casadevall, A. (2003). The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 5, 667-675. (Pubitemid 36645127)
23. Wang, Y., Aisen, P. & Casadevall, A. (1995). Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun 63, 3131-3136.
24. Williamson, P. R. (1994). Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J Bacteriol 176, 656-664. (Pubitemid 24043954)
25. Williamson, P. R., Wakamatsu, K. & Ito, S. (1998). Melanin biosynthesis in Cryptococcus neoformans. J Bacteriol 180, 1570-1572.